WA
The startup develops activatable nanoparticles that enhance the visibility and treatment efficacy of hard-to-reach tumors through MRI-directed, remotely activatable therapeutics. This technology enables clinicians to effectively target deep-seated tumors, reducing adverse effects and minimizing the need for multiple hospital visits.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops activatable nanoparticles that enhance the visibility and treatment efficacy of hard-to-reach tumors through MRI-directed, remotely activatable therapeutics. This technology enables clinicians to effectively target deep-seated tumors, reducing adverse effects and minimizing the need for multiple hospital visits.